More about Sun Pharmaceutical Industries Limited
Fundamentals for Sun Pharmaceutical Industries Limited
Regulatory Filings for Sun Pharmaceutical Industries Limited
Tier 2 Towns Are Outsaving India's Big Metros
The Renewable Success Story Beyond Solar
Startups Mint India’s New Billionaires
India's Biggest IPO Has a Bigger Meaning
Technicals for Sun Pharmaceutical Industries Limited
Price Summary
On 2026-07-01, Sun Pharmaceutical Industries Limited's stock began at 1877.9, peaked at 1887.4, bottomed at 1860.2, and closed -0.62% lower at 1866.2, with a volume of 1230335 shares.The peak price for the stock in the past 52 weeks is 1905.8, with the lowest price being 1563.3.
Technicals
Support and Resistance: With the current price at 1866.2, support is found at 1825.9 and resistance at 1872.7. These levels indicate where buyers might step in at 1825.9, while sellers could limit gains at 1872.7, defining a trading boundary for Sun Pharmaceutical Industries Limited.Aroon: The AROON is neutral, showing no definitive signals of a trend either upward or downward. This neutral stance indicates a period of market indecision, where the direction is unclear.
Bol. Bands: The BOLL BANDS is currently neutral, showing no clear bias toward a rising or falling trend. This lack of directional clarity suggests that the market may be in a holding pattern, awaiting further developments.
Parabolic SAR: The PSAR for Sun Pharmaceutical Industries Limited has recently turned from bullish to bearish, suggesting a potential trend change. This reversal could be a strong bearish signal if it aligns with other market indicators. Investors should monitor the situation and wait for further confirmation before making any moves.
Stochastic: The current reading of the STOCHASTIC is neutral, offering no clear signals for a movement in either direction. This suggests that the market may be in a holding pattern, with no dominant trend in place.
Tripple Moving Agerage: The alignment of the 20, 50, and 100 moving averages points to a bearish trend for Sun Pharmaceutical Industries Limited, but the wavering slopes of the 20 and 50 SMAs indicate that this momentum may be weakening. This loss of strength could be a sign that the market is approaching a turning point, with the possibility of a bullish reversal on the horizon. Investors should watch for signs of a trend change as the current downtrend starts to fade.
Before focusing on a company's technical data, such as stock price movements, it's essential to analyze its fundamentals. These include factors like profitability, cash flow, and debt management. Additionally, considering the broader industry landscape—including market trends, competition, and regulatory changes—offers deeper insights. This comprehensive approach allows for a more meaningful interpretation of the company's technical indicators, providing a clearer picture of its financial health and future prospects.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
From Watches to Wealth: Titan's New Empire
SEBI's New Gateway Is Rewiring Foreign Investment in India
Why Japan Backs India’s Truckers